Significant advancements in improving the health care of underrepresented minorities will be dependent on educating and training larger numbers of minority health care providers and scientists. The biomedical research arm of TSU became a powerful expression of this ideal with the construction of a 19,380 square feet addition to the Gray Hall Pharmacy building that houses the Center for Cardiovascular Diseases, a molecular biology core facility, a vivarium, and a level three biosafety lab. This upgrade coupled with the TMC facility provides over 1000,000 square feet of instructional, laboratory, and office area for faculty, staff and students and helps to position the COPHS as a national resource for minority health professionals and scientists. COPHS faculty and research scientists are conducting research in several areas including atherosclerosis, cancer, hypertension, diabetes, tuberculosis, HIV/AIDS, drug delivery, pharmacokinetics, glaucoma, and comparative effectiveness. For fiscal year 2011-2012, the COPHS received almost $6,000,000 to support research, instruction and other endeavors. The COPHS emphasizes a community-based approach to research working alongside community partners to collaborate on projects to address the needs of the community. A specific area of focus involves emergency preparedness and medication adherence in the geriatric population. The COPHS has received funding from the US Department of Health and Human Services to further research in the effectiveness of pharmacist home-based models. The research programs in the College are anchored by three National Institutes of Health (NIH)- supported research centers of research that have, as a common theme, the elimination of health disparities. The centers include the Institute for Biomedical and Health Disparities Research (National Institute for Minority Health and Health Disparities), the Center for Cardiovascular Diseases (National Heart, Lung and Blood Institute), and the Center for Health Disparities Research: Cardiovascular Diseases and HIV (National Heart, Lung and Blood Institute).